BIOL vs. DYNT, IONM, SDCCQ, GMVDF, VRAYQ, AHPI, NMRD, VIVE, BRSH, and UTRS
Should you be buying BIOLASE stock or one of its competitors? The main competitors of BIOLASE include Dynatronics (DYNT), Assure (IONM), SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), ViewRay (VRAYQ), Allied Healthcare Products (AHPI), Nemaura Medical (NMRD), Viveve Medical (VIVE), Bruush Oral Care (BRSH), and Minerva Surgical (UTRS). These companies are all part of the "medical equipment" industry.
BIOLASE vs.
Dynatronics (NASDAQ:DYNT) and BIOLASE (NASDAQ:BIOL) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.
Dynatronics has a net margin of -8.88% compared to BIOLASE's net margin of -41.65%. Dynatronics' return on equity of -41.41% beat BIOLASE's return on equity.
Dynatronics received 17 more outperform votes than BIOLASE when rated by MarketBeat users. However, 52.42% of users gave BIOLASE an outperform vote while only 48.21% of users gave Dynatronics an outperform vote.
Dynatronics has higher earnings, but lower revenue than BIOLASE. Dynatronics is trading at a lower price-to-earnings ratio than BIOLASE, indicating that it is currently the more affordable of the two stocks.
BIOLASE has a consensus price target of $1.20, suggesting a potential upside of 13,383.15%. Given BIOLASE's stronger consensus rating and higher probable upside, analysts clearly believe BIOLASE is more favorable than Dynatronics.
In the previous week, BIOLASE had 1 more articles in the media than Dynatronics. MarketBeat recorded 1 mentions for BIOLASE and 0 mentions for Dynatronics. Dynatronics' average media sentiment score of 0.00 equaled BIOLASE'saverage media sentiment score.
Dynatronics has a beta of 0.13, suggesting that its share price is 87% less volatile than the S&P 500. Comparatively, BIOLASE has a beta of 0.67, suggesting that its share price is 33% less volatile than the S&P 500.
4.2% of Dynatronics shares are held by institutional investors. Comparatively, 8.8% of BIOLASE shares are held by institutional investors. 8.0% of Dynatronics shares are held by company insiders. Comparatively, 0.3% of BIOLASE shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Summary
Dynatronics and BIOLASE tied by winning 8 of the 16 factors compared between the two stocks.
Get BIOLASE News Delivered to You Automatically
Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (NASDAQ:BIOL) was last updated on 1/21/2025 by MarketBeat.com Staff
Free BIOL Stock Alerts